PubMed

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.

Zekri AR, Alam El-Din HM, Bahnassy AA, Zayed NA, Mohamed WS, El-Masry SH, Gouda SK, Esmat G.

Comp Hepatol. 2010 Jan 5;9(1):1. [Epub ahead of print]PMID: 20051112 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.

Zekri AR, Haleem HA, Esmat GE, Bahnassy AA, El-Din HM, Hafez MM, Sharaby AF, Sharaf H, Zakaria MS.

J Viral Hepat. 2007 Jul;14(7):468-77.PMID: 17576388 [PubMed - indexed for MEDLINE]Related citations

Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.

Huang YS, Hwang SJ, Chan CY, Wu JC, Chao Y, Chang FY, Lee SD.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 Jun;62(6):327-33.PMID: 10389289 [PubMed - indexed for MEDLINE]Related citations

Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.

Zekri AR, Ashour MS, Hassan A, Alam El-Din HM, El-Shehaby AM, Abu-Shady MA.

World J Gastroenterol. 2005 Nov 14;11(42):6624-30.PMID: 16425355 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.

Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, Daniele B, Curley SA.

Ann Surg Oncol. 1999 Mar;6(2):178-85.PMID: 10082044 [PubMed - indexed for MEDLINE]Related citations

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.

Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, Yoshioka K, Yoshika Y.

Clin Exp Immunol. 1997 Sep;109(3):458-63.PMID: 9328122 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood.

Macías J, Sánchez-Quijano A, Pineda JA, Abad MA, Rubio A, Rosa R, Leal M, Lissen E.

Liver. 2001 Dec;21(6):410-4.PMID: 11903886 [PubMed - indexed for MEDLINE]Related citations

Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.

Kitaoka S, Shiota G, Kawasaki H.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1569-74.PMID: 14571788 [PubMed - indexed for MEDLINE]Related citations

Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.

Emam EA, Emam M, Shehata AE, Emara M.

Egypt J Immunol. 2006;13(2):33-40.PMID: 18689269 [PubMed - indexed for MEDLINE]Related citations

Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.

Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM.

Clin Biochem. 2006 Jun;39(6):623-9. Epub 2006 Apr 19.PMID: 16624274 [PubMed - indexed for MEDLINE]Related citations

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

Chen DS.

Princess Takamatsu Symp. 1995;25:27-32. Review.PMID: 8875606 [PubMed - indexed for MEDLINE]Related citations

Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.

Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, Yoshioka K.

J Gastroenterol Hepatol. 2000 Apr;15(4):431-6.PMID: 10824889 [PubMed - indexed for MEDLINE]Related citations

Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.

Helaly GF, Abou Shamaa LA.

Egypt J Immunol. 2006;13(1):27-38.PMID: 17974148 [PubMed - indexed for MEDLINE]Related citations

Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.

Tai DI, Tsai SL, Chen TC, Lo SK, Chang YH, Liaw YF.

J Biomed Sci. 2001 Jul-Aug;8(4):321-7.PMID: 11455194 [PubMed - indexed for MEDLINE]Related citations

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.

Jodo S, Kobayashi S, Nakajima Y, Matsunaga T, Nakayama N, Ogura N, Kayagaki N, Okumura K, Koike T.

Clin Exp Immunol. 1998 May;112(2):166-71.PMID: 9649177 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.

El Bassiouny AE, El-Bassiouni NE, Nosseir MM, Zoheiry MM, El-Ahwany EG, Salah F, Omran ZS, Ibrahim RA.

Medscape J Med. 2008 Jun 3;10(6):130.PMID: 18679533 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Relationship between HLA-DRB1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients.

Hamed NA, Hano AF, Raouf HA, Gamal M, Eissa M.

Egypt J Immunol. 2003;10(1):17-26.PMID: 15719619 [PubMed - indexed for MEDLINE]Related citations

Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection.

Kim HG, Chung YH, Song BC, Kim J, Yang SH, Lee YS, Suh DJ.

Korean J Intern Med. 2000 Dec;15(3):165-70.PMID: 11242803 [PubMed - indexed for MEDLINE]Related citations

Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.

Tarao K, Rino Y, Ohkawa S, Tamai S, Miyakawa K, Takakura H, Endo O, Yoshitsugu M, Watanabe N, Matsuzaki S.

Cancer. 2002 Mar 15;94(6):1787-95.PMID: 11920542 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Soresi M, Giannitrapani L, D'Antona F, Florena AM, La Spada E, Terranova A, Cervello M, D'Alessandro N, Montalto G.

World J Gastroenterol. 2006 Apr 28;12(16):2563-8.PMID: 16688802 [PubMed - indexed for MEDLINE]Free ArticleRelated citations